Ingvild Van Petegem’s Post

CX 2024 welcomes a revolutionised Carotid and Acute Stroke programme (Wednesday 24 April) which, for the first time, expands upon carotid indications, new technologies and neurointeventions. Take a look at the series of upcoming debates below! 🆕 Domenico Valenti 🗣️ Debate: Patients with symptomatic near occlusion in the internal carotid artery (ICA) should only be treated medically Konstantinos Antonopoulos Rantner Barbara, MD, PhD, FEBVS 🗣️ Debate: Best medical treatment (BMT) only is as effective as carotid endarterectomy (CEA) or carotid artery stenting (CAS) in patients with symptomatic internal carotid artery (ICA) stenosis Melina De Vega De Ceniga 🗣️ Debate: Patients with symptomatic carotid artery web should only be treated medically Maarit Venermo 🗣️ Debate: CAS is the treatment of choice for underlying ICA stenosis after mechanical thrombectomy 🗣️ Debate: Patients with vertebro-basilar ischaemia should be treated with endovascular intervention Levansri Makalanda ➡️ View the programme in full: https://lnkd.in/eBiwitAf

Professor Dainis Krievins, MD, PhD : 2024 #VEITHsymposium, Tuesday, November 19 - Saturday, November 23, 2024. Presentation SCHEDULE FOR VEITHsymposium™: SESSION 10: NEW DEVELOPMENTS IN CAROTID DISEASE AND ITS TREATMENT; DIFFERING VIEWS ON TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS) AND CAROTID SCREENING. SESSION 28: NEW DEVELOPMENTS IN PROSTHETIC GRAFTS; STENT GRAFTS; PERCUTANEOUS ENDOVASCULAR BYPASSES; STENT OCCLUSIONS AND TREATMENT OF IN STENT RESTENOSIS (ISR). SESSION 62: NEW OR IMPROVED DEVICES AND TECHNIQUES TO PREVENT OR TREAT ENDOLEAKS OR DEVICE MIGRATION: ENDOANCHORS, ETC. https://lnkd.in/ezhVJ83v

Follow Clinical club https://lnkd.in/eDh4M7VY Thrombolysis Beneficial for ‘Eye Stroke’? Thrombolysis to treat central retinal artery occlusion, also known as “eye stroke,” appeared to improve visual acuity compared with oral aspirin but this did not reach statical significance, results from a randomized control trial showed. If patients met inclusion criteria, they were randomized to receive either IV alteplase (at the standard dose) plus oral placebo or IV placebo plus oral aspirin 300 mg. Results showed that both the thrombolysis group and the aspirin group experienced significantly improved visual acuity at 1 month. The key safety endpoint — intracranial hemorrhage (ICH) occurred in one patient in the alteplase group (ICH was asymptomatic) vs zero in the aspirin group. If the occlusion is caused by a calcified plug, then thrombolysis would not work, so we have to find the cases where it’s more of a thrombus,” Link: https://lnkd.in/e96KXvGk #clinicalclub

Revolutionizing cardiac care! Abbott has received FDA clearance for the i-STAT hs-TnI cartridge, the first-fully portable, high-sensitivity cardiac troponin I assay at the bedside. Enable rapid assessment of patients presenting with chest pain, potentially leading to faster triage and treatment of myocardial infarction (MI) patients. Learn more about how this innovation can transform your cardiac care protocols. https://lnkd.in/gDYsmePu #PointofCare #POC #CardiacDiagnostics #Troponin #FDACleared #Innovation #Abbott

In this on-demand clinical snippet, Dr. Marc Humbert provides an in-depth exploration of managing atypical PAH patients, who often present with complex profiles, including older age, cardiovascular comorbidities, and pulmonary issues.   Click the link in our bio to complete a brief post-test/evaluation and receive AMA, ANCC, or ACPE credit!   #PAH #Pulmonology #CME #continuingmedicaleducation

The A-OK method is one of the only resuscitative acronyms for AFE patients, and is designed to remind clinicians of some off label pharmacologic interventions that may be effective in a last ditch effort. A- Atropine 1mg: Atropine may serve to reverse parasympathetic activity that contributes to vasospasm. O- Ondansetron 8mg: Ondansetron blocks receptors that may be found in the heart and lungs which contribute to pulmonary vasoconstriction and subsequent cor pulmonale. K- Ketorolac 30mg: Ketorolac blocks thromboxane, which is a platelet activator. This blockade is thought to assist with the slowing of hemorrhage by reducing platelet response.

#FORZA trial: 5-year clinical outcomes 📉 For the management of patients with angiographically intermediate coronary stenosis, #OCT and #FFR guidance had a similar risk of MACE at 5 years Thrilled to share our manuscript just published in the European Heart Journal #EHJ

Understanding the nuances of treatment response in severe COPD is crucial. Beyond radiological outcomes and lung function improvements, patient perception is paramount. Recent studies suggest a TLVR >50% leads to meaningful outcomes, complemented by exercise capacity and quality of life measures. Let's prioritize holistic patient-centered care in COPD management.

Aortic Dissection Pearls In this article you will learn everything and more about Aortic Dissections. Identify the clinical signs and symptoms of aortic dissection to ensure timely recognition in patients presenting with chest pain. Differentiate between aortic dissection and other potential causes of acute chest pain, such as myocardial infarction or pulmonary embolism. Select the most effective pharmacologic interventions to manage blood pressure and heart rate in patients with aortic dissection. Collaborate with surgical and medical teams to develop a comprehensive management plan for patients diagnosed with aortic dissection. To read more of this amazing article, just click on the link below: https://lnkd.in/gb3jZnFS #aortaed #aortichope